Unlike the data from Chrisholm et al., who did not observe growth inhibitory effects of EGCG in ERα-positive breast cancer cells (31), we found EGCG alone at physiological levels did have inhibitory actions on cell growth in MCF7 cells. Here, ESR1 is linked to breast cancer.